Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$105K Buy
401
+27
+7% +$8.01K 0.03% 230
2024
Q3
$121K Buy
374
+46
+14% +$15K 0.03% 243
2024
Q2
$102K Sell
328
-25
-7% -$7.34K 0.03% 252
2024
Q1
$100K Buy
+353
New +$103K 0.03% 255
2023
Q4
Sell
-334
Closed -$89.8K 213
2023
Q3
$89.8K Hold
334
0.03% 256
2023
Q2
$74.2K Buy
334
+60
+22% +$13.9K 0.03% 274
2023
Q1
$66.3K Buy
274
+74
+37% +$18.2K 0.03% 284
2022
Q4
$52.5K Sell
200
-12
-6% -$3.22K 0.03% 169
2022
Q3
$47.8K Buy
212
+12
+6% +$2.91K 0.03% 164
2022
Q2
$48.7K Hold
200
0.03% 174
2022
Q1
$48.4K Buy
+200
New +$46K 0.03% 174

Other funds holding AMGN

WR Wealth Planners's AMGN Position: Q4 2024 in Review

WR Wealth Planners increased its Amgen (AMGN) stake by 7.2% in Q4 2024, buying an estimated $8.01K and bringing the position to 401 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #230.

WR Wealth Planners first reported a position in AMGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $121K in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • WR Wealth Planners held 401 shares of Amgen worth $105K as of Q4 2024.
  • WR Wealth Planners bought 27 Amgen shares in Q4 2024, an estimated $8.01K.
  • Amgen made up 0.03% of WR Wealth Planners's portfolio in Q4 2024, its #230 holding.
  • WR Wealth Planners first reported a position in Amgen in Q1 2022 and has held it in 11 quarters since.
  • WR Wealth Planners's Amgen position peaked at $121K in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.